KATO PHARMACEUTICALS
Kato is a clinical stage Bio-pharmaceutical company dedicated to the development of novel therapies for pathologies of the eye with an emphasis on unmet medical needs.
KATO PHARMACEUTICALS
Industry:
Biopharma Biotechnology Medical Pharmaceutical
Founded:
2011-01-01
Address:
Laguna Hills, California, United States
Country:
United States
Website Url:
http://www.katopharma.com
Status:
Active
Contact:
(949) 348-1188
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Microsoft Exchange Online Amazon Office 365 Mail Cloudflare JS
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Integrated Pharma Services
Integrated Pharma Services is a biotechnology company specialized in the development and testing of novel therapeutics and diagnostics.
Mateon Therapeutics
Mateon Therapeutics is a biopharmaceutical company dedicated to developing vascular targeted therapy (VTT) for orphan oncology indications.
Natura Naturals (Natura)
Natura Naturals is a Pharmaceutical company which is currently licensed for cultivation.
Pearko Therapeutics
Pearko Therapeutics provides pharmacological therapies to patients with cardiovascular disease through innovative technologies.
Plumbline Life Sciences
Plumbline Life Sciences is an animal biopharmaceutical company based on innovative DNA vaccine platform technology
Yamo Pharmaceuticals
Yamo Pharmaceuticals is a clinical-stage pharmaceutical company that develops L1-79, a novel therapy for Autism spectrum disorder.
Current Employees Featured
Founder
Official Site Inspections
http://www.katopharma.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Kato Pharmaceuticals"
Karo Healthcare - Crunchbase Company Profile
Karo Pharma is a pharmaceutical company. The company develops and markets products for pharmacies and directly to the healthcare sector. The product portfolio includes over-the-counter and prescription pharmaceuticals as well …See details»
Karo Pharma publishes the 2020 annual report - Karo Healthcare
Jon Johnsson, CFO, 073-507 88 61, [email protected]. The Annual Report is published in Swedish and English. The Swedish version represents the original version and …See details»
Karo Pharma - EQT Group
Nov 22, 2022 About. About EQT EQT is a purpose-driven global investment organization with EUR 114 billion in assets under management within two business segments – Private Capital …See details»
Karo Pharma AB Company Profile - GlobalData
Website www.karopharma.se Telephone 46 8 4443820. No of Employees 242. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange KARO (STO) Revenue (2022) …See details»
Contact - Karo Healthcare
[email protected] +41 61 465 70 40: United Kingdom: [email protected] +44 (0) 8000461977: United States: [email protected]: Other countries: [email protected]: We are …See details»
Karo Pharma publishes the 2021 annual report - Karo Healthcare
Jon Johnsson, CFO, 073-507 88 61, [email protected]. The Annual Report is published in Swedish and English. The Swedish version represents the original version and …See details»
Karo Pharma - Craft
Nov 23, 2022 Karo Pharma has 5 employees across 2 locations and kr2.96 b in annual revenue in FY 2021. See insights on Karo Pharma including office locations, competitors, revenue, …See details»
Karo Pharma publishes the 2021 annual report - Karo Pharma
Today, on 12 April 2022, Karo Pharma is publishing its annual report for 2021 on the company’s website, www.karopharma.com. For further information, please contact: Lisa Westerdahl, …See details»
Karo Healthcare - EQT Group
About Karo Healthcare Karo Healthcare sells and markets a portfolio of everyday healthcare products that help prevent illnesses and treat everyday health problems. The portfolio …See details»
Karo Pharma publishes the 2021 annual report - MarketScreener
Today, on 12 April 2022, Karo Pharma is publishing its annual report for 2021 on the company's website, www.karopharma.com.. For further information, please contact: Lisa Westerdahl, …See details»
Karo Pharma CEO and Key Executive Team | Craft.co
Karo Pharma's Chief Executive Officer is Christoffer Lorenzen. Other executives include Jon Johnsson, Chief Financial Officer; Carl Lindgren, Vice President Business Development and 3 …See details»
Karo Pharma: Year-end report 2021 - PR Newswire
Feb 25, 2022 Christoffer Lorenzen, CEO, +46 73-501 76 20, [email protected] Jon Johnsson , CFO, +46 73-507 88 61, …See details»
Karo Pharma completes the acquisition of the brand portfolio …
Christoffer Lorenzen, CEO, +4673-501 76 20, [email protected] Carl Lindgren, VP Business Development, +4676-002 60 22, [email protected]. …See details»
Karo Pharma completes the acquisition of the brand portfolio …
Apr 1, 2021 Christoffer Lorenzen, CEO, +4673-501 76 20, [email protected] Carl Lindgren , VP Business Development, +4676-002 …See details»
Karo Pharma Quarterly report Q3 2021 - Karo Healthcare
[email protected]. CEO Jon Johnsson, CFO +46 73-507 88 61 [email protected]. About Karo Pharma. Karo Pharma offers “Smart choices for …See details»
Karo Pharma completes the acquisition of the brand portfolio …
Jan 4, 2021 Christoffer Lorenzen, CEO, +4673-501 76 20, [email protected] Carl Lindgren, VP Business Development, +4676-002 …See details»
Karo Pharma acquires European OTC brand portfolio from Teva ...
Feb 3, 2021 Christoffer Lorenzen, CEO, +4673-501 76 20, [email protected] Carl Lindgren, VP Business Development, +4676-002 …See details»
Karo Pharma completes the acquisition of Sylphar International NV
Jan 13, 2022 Carl Lindgren, VP Business Development, +46 760 026 022, [email protected] . This information is such that Karo Pharma Aktiebolag (publ) …See details»
Karo Pharma completes the acquisition of the E45® brand from …
Apr 1, 2022 Christoffer Lorenzen, CEO, +46 735 017 620, [email protected] Carl Lindgren , VP Business Development, +46 760 …See details»
Karo Pharma enters into an agreement for the potential …
Christoffer Lorenzen, CEO, +46735017 620, [email protected] Carl Lindgren, VP Business Development, +46760026 022, [email protected] This …See details»